Granite Bio
Latest round
- Series B
Last raised
- Apr 2025
Total raised
- $100M
Investors
- 5
About Granite Bio
Based in Basel, Switzerland, and founded in 2021, Granite Bio AG operates as a pre-clinical and clinical stage biotech company focused on developing therapies for inflammation, autoimmunity, and fibrosis. Granite Bio AG, based in Basel, Switzerland, focuses on developing novel therapies for chronic inflammatory, autoimmune, and fibrotic diseases. The company’s lead assets, GRT-001 and GRT-002, aim to target the fundamental biology underlying these conditions. GRT-001 is an antibody designed to deplete pro-inflammatory monocytes, while GRT-002 targets novel disease biology identified through proprietary patient profiling.
Who invested in Granite Bio
5 investors across 2 rounds
See all investors in Granite Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Granite Bio
Who invested in Granite Bio?
Granite Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Granite Bio raised?
Granite Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Granite Bio last raise money?
Granite Bio's most recent round on record is a Series B, in Apr 2025.
What does Granite Bio do?
Based in Basel, Switzerland, and founded in 2021, Granite Bio AG operates as a pre-clinical and clinical stage biotech company focused on developing therapies for inflammation, autoimmunity, and fibrosis.
Where is Granite Bio headquartered?
Granite Bio is headquartered in Basel, Switzerland.
Which VCs invest in companies like Granite Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Granite Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Granite Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.